| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biomedical Sciences and Oncology (P.C., A.S., G.B.), Department of Animal and Human Biology and National Institute for the Physics of Matter (L.M.), and Laboratory of Cell Biology, Department of Genetics (S.D.), University of Turin, 10126 Turin, Italy; Department of Medical Sciences, University of Novara (A.G.), 28100 Novara, Italy; Consiglio Nationale per le Ricerche Cellular and Molecular Pharmacology Center (B.C.), 20129 Milan, Italy; and Department of Reproductive and Vascular Biology, Division of Reproductive and Child Health, University of Birmingham (A.A.), Birmingham Womens Hospital, Birmingham, B15 2TG, United Kingdom
Address all correspondence and requests for reprints to: Dr. Gianni Bussolati, Department of Biomedical Sciences and Oncology, University of Turin, Via Santena 7, 10126 Turin, Italy. E-mail: bussola{at}molinette.unito.it
Despite oxytocin receptors (OTR) being present in human chorio-decidual tissues, their expression and role in placental trophoblast cells in the context of tumor growth or physiological functions related to cell proliferation have never been examined. In the present study we demonstrate the presence and functionality of OTR in normal human trophoblast cell lines (ED77 and ED27) and a choriocarcinoma cell line (BeWo). RT-PCR and immunofluorescence analysis revealed the presence of OTR messenger RNA and protein in these cells. Binding studies using [125I]oxytocin ([125I]OT) antagonist confirmed the presence of specific binding sites in ED27, ED77, and BeWo cells. OTR functionality was demonstrated by measuring the OT-induced increase in the intracellular calcium concentrations. This effect was dose dependent and was blocked by the selective OT antagonist d(CH2)5[Tyr(Me)2,Thr4, Tyr-NH29]OVT (OT antagonist). Furthermore, two proteins with apparent molecular masses of 125 and 60 kDa became tyrosine phosphorylated in all of the cell lines after OT stimulation (and an additional protein of 45 kDa in BeWo choriocarcinoma cells), suggesting that this peptide can stimulate tyrosine kinase activity. Finally, we observed a dose-dependent OT stimulation of cell proliferation associated with OTR activation that was completely abolished by the selective OT antagonist. These findings provide the first evidence of the presence of functional OTR in normal trophoblast cell lines as well as in choriocarcinoma cells and show that a specific effect of OT on normal and neoplastic trophoblast is to promote cellular proliferation.
This article has been cited by other articles:
![]() |
M. U. Baumann, S. Zamudio, and N. P. Illsley Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1 Am J Physiol Cell Physiol, July 1, 2007; 293(1): C477 - C485. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Reversi, V. Rimoldi, S. Brambillasca, and B. Chini Effects of cholesterol manipulation on the signaling of the human oxytocin receptor Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R861 - R869. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Reversi, V. Rimoldi, T. Marrocco, P. Cassoni, G. Bussolati, M. Parenti, and B. Chini The Oxytocin Receptor Antagonist Atosiban Inhibits Cell Growth via a "Biased Agonist" Mechanism J. Biol. Chem., April 22, 2005; 280(16): 16311 - 16318. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vignozzi, G. B. Vannelli, A. Morelli, R. Mancina, M. Marini, P. Ferruzzi, C. Crescioli, M. Luconi, S. Donati, A. D. Fisher, et al. Identification, characterization and biological activity of oxytocin receptor in the developing human penis Mol. Hum. Reprod., February 1, 2005; 11(2): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jankowski, B. Danalache, D. Wang, P. Bhat, F. Hajjar, M. Marcinkiewicz, J. Paquin, S. M. McCann, and J. Gutkowska Oxytocin in cardiac ontogeny PNAS, August 31, 2004; 101(35): 13074 - 13079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuura, T. Nagai, N. Nishigaki, T. Oyama, J. Nishi, H. Wada, M. Sano, H. Toko, H. Akazawa, T. Sato, et al. Adult Cardiac Sca-1-positive Cells Differentiate into Beating Cardiomyocytes J. Biol. Chem., March 19, 2004; 279(12): 11384 - 11391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhong, M. Yang, and B. M. Sanborn Extracellular Signal-Regulated Kinase 1/2 Activation by Myometrial Oxytocin Receptor Involves G{alpha}qG{beta}{gamma} and Epidermal Growth Factor Receptor Tyrosine Kinase Activation Endocrinology, July 1, 2003; 144(7): 2947 - 2956. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pequeux, C. Breton, J.-C. Hendrick, M.-T. Hagelstein, H. Martens, R. Winkler, V. Geenen, and J.-J. Legros Oxytocin Synthesis and Oxytocin Receptor Expression by Cell Lines of Human Small Cell Carcinoma of the Lung Stimulate Tumor Growth through Autocrine/Paracrine Signaling Cancer Res., August 15, 2002; 62(16): 4623 - 4629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Paquin, B. A. Danalache, M. Jankowski, S. M. McCann, and J. Gutkowska Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes PNAS, July 9, 2002; 99(14): 9550 - 9555. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, and G. Bussolati Oxytocin Is a Growth Factor for Kaposi's Sarcoma Cells: Evidence of Endocrine-Immunological Cross-Talk Cancer Res., April 1, 2002; 62(8): 2406 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bussolati, M. Chinol, B. Chini, A. Nacca, P. Cassoni, and G. Paganelli 111In-labeled 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic Acid-Lys8-Vasotocin: A New Powerful Radioligand for Oxytocin Receptor-expressing Tumors Cancer Res., June 1, 2001; 61(11): 4393 - 4397. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bussolati and P. Cassoni Editorial: The Oxytocin/Oxytocin Receptor System--Expect the Unexpected Endocrinology, April 1, 2001; 142(4): 1377 - 1379. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |